The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003
Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men
Finkle, W. D., Greenland, S., Ridgeway, G. K., Adams, J. L., Frasco, M. A., Cook, M. B., Fraumeni, J. F., & Hoover, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085805 · Cited by 735
Research works printed but not linked: 27
- Traish, 2014, Adverse health effects of testosterone deficiency (TD) in men, Steroids, 88, 106, 10.1016/j.steroids.2014.05.010 · DOI
- Bhasin, 2006, Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metabol, 91, 1995, 10.1210/jc.2005-2847 · DOI · Paper page
- Ohlsson, 2011, High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden, J Am Coll Cardiol, 58, 1674, 10.1016/j.jacc.2011.07.019 · DOI · Paper page
- Xu, 2013, Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials, BMC Med, 11, 108, 10.1186/1741-7015-11-108 · DOI · Paper page
- Baillargeon, 2014, Risk of myocardial infarction in older men receiving testosterone therapy, Ann Pharmacother, 48, 1138, 10.1177/1060028014539918 · DOI · Paper page
- Sharma, 2015, Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men, Eur Heart J, 36, 2706, 10.1093/eurheartj/ehv346 · DOI · Paper page
- Shores, 2012, Testosterone treatment and mortality in men with low testosterone levels, J Clin Endocrinol Metabol, 97, 2050, 10.1210/jc.2011-2591 · DOI · Paper page
- Muraleedharan, 2013, Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes, Eur J Endocrinol, 169, 725, 10.1530/EJE-13-0321 · DOI · Paper page
- Anderson, 2015, Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system, Am J Cardiol, 117, 794, 10.1016/j.amjcard.2015.11.063 · DOI
- Corona, 2015, Testosterone replacement therapy and cardiovascular risk: a review, World J Mens Health, 33, 130, 10.5534/wjmh.2015.33.3.130 · DOI
- Goodman, 2015, American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of testosterone and cardiovascular risk, Endocr Pract, 21, 1066, 10.4158/EP14434.PS · DOI
- Dean, 2005, Long-term effects of testim(r) 1% testosterone gel in hypogonadal men, Rev Urol, 7, 87
- 2015, Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies, Lancet, 385, 1835, 10.1016/S0140-6736(14)61687-1 · DOI · Paper page
- Etminan, 2015, Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study, Pharmacotherapy, 35, 72, 10.1002/phar.1534 · DOI
- Levy, 2003, Coding accuracy of administrative drug claims in the Ontario Drug Benefit database, Can J Clin Pharmacol, 10, 67
- Tu, 1999, Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992–1996, CMAJ, 161, 1257
- Hux, 2002, Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm, Diabetes Care, 25, 512, 10.2337/diacare.25.3.512 · DOI · Paper page
- Robles, 1988, An application of capture-recapture methods to the estimation of completeness of cancer registration, J Clin Epidemiol, 41, 495, 10.1016/0895-4356(88)90052-2 · DOI · Paper page
- Mittmann, 2012, Population-based home care services in breast cancer: utilization and costs, Curr Oncol, 19, e383, 10.3747/co.19.1078 · doi:10.3747/co.19.1078
- Piszczek, 2014, The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men, PLoS One, 9, e98003, 10.1371/journal.pone.0098003 · DOI
- Austin, 2009, Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research, Commun Stat Simul Comput, 38, 1228, 10.1080/03610910902859574 · DOI · Paper page
- Shintani, 2009, Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies, Crit Care Med, 37, 2939, 10.1097/CCM.0b013e3181b7fbbb · DOI · Paper page
- Daniel, 2015, Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure, Am J Obstet Gynecol, 212, 307.e1, 10.1016/j.ajog.2014.09.028 · DOI
- Stricker, 2010, Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies, Eur J Epidemiol, 25, 245, 10.1007/s10654-010-9451-7 · DOI
- Morgentaler, 2014, Deaths and cardiovascular events in men receiving testosterone, JAMA, 311, 961, 10.1001/jama.2014.392 · DOI
- Cui, 2014, The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis, Prostate Cancer Prostatic Dis, 17, 132, 10.1038/pcan.2013.60 · DOI
- Hernan, 2008, Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease, Epidemiology, 19, 766, 10.1097/EDE.0b013e3181875e61 · DOI · Paper page
Cited by
Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management
Fernandez, C. J., Department of Endocrinology & Metabolism, P. H., Chacko, E. C., Department of Endocrinology, J. G. H., Pappachan, J. M., & Department of Endocrinology & Metabolism, L. T. H. N. F. T. (2019) · European Endocrinology · doi:10.17925/ee.2019.15.2.83 · Cited by 145
Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies
Corona, G., Rastrelli, G., Di Pasquale, G., Sforza, A., Mannucci, E., & Maggi, M. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.04.641 · Cited by 138
Traish, A. M., Haider, A., Haider, K. S., Doros, G., & Saad, F. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417691136 · Cited by 130
Testosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
The chronic alcohol consumption influences the gonadal axis in men: Results from a meta‐analysis
Santi, D., Cignarelli, A., Baldi, M., Sansone, A., Spaggiari, G., Simoni, M., & Corona, G. (2024) · Andrology · doi:10.1111/andr.13526 · Cited by 17
Metadata
- Authors
- Wallis, C. J. D., Lo, K., Lee, Y., Krakowsky, Y., Garbens, A., Satkunasivam, R., Herschorn, S., Kodama, R. T., Cheung, P., Narod, S. A., & Nam, R. K.
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 4
- Issue
- 6
- Pages
- 498-506
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2346770749
- Cited by
- 161
- References
- 3
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Government of Ontario
- Physicians' Services Incorporated Foundation
- Canadian Institutes of Health Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. https://app.cochat.ai/papers/10.1016/s2213-8587(16)00112-1
- The paper
- Wallis, C. J. D., Lo, K., Lee, Y., Krakowsky, Y., Garbens, A., Satkunasivam, R., Herschorn, S., Kodama, R. T., Cheung, P., Narod, S. A., & Nam, R. K. (2016). Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(16)00112-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.